← Leaderboards
Se-Min Kim
Icahn School Of Medicine At Mount Sinai
$2,209,838
Attributed
$4,791,603
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,791,603 · 2
By mechanism
R01$3,872,647 · 1
U19$918,956 · 1
Top collaborators
- Tony Yuen6 shared
- Mone Zaidi6 shared
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Mone Zaidi$25,912,145
- Tony Yuen$10,254,831
- Clifford J Rosen$37,701,781
- Daria Lizneva$1,362,850
Others in their field
Other Emerging Leaders on “Brain”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Susan Abushakra · Alzheon, Inc.$50,765,244
- Susan M Landau · University Of California Berkeley$47,252,026
- Evan Z Macosko · Broad Institute, Inc.$36,871,464
- Greg Yothers · University Of Chicago$35,003,821
- Anthony Philippakis · University Of California Santa Cruz$30,961,549
Research focus
BrainPreventMapsBoneCellsOverexpressionMolecularFutureBone LossAgingSafetyOsteoclastsHormonesCyclic Gmp-Dependent Protein KinasesDrug RepurposingMediatingNitric OxideDrug ActionInvestigationFemaleBrain RegionAgedCyclic GmpEnzymes
Grant awards (8)
Proof-of-Concept and Mechanistic Studies to Repurpose Erectile Dysfunction Drugs for Elderly Females$678,675
R01 · FY2025 · AG
Antibody Production and Testing Core (APTC)$580,385
U19 · FY2025 · AG · contact PI
Proof-of-Concept and Mechanistic Studies to Repurpose Erectile Dysfunction Drugs for Elderly Females$692,527
R01 · FY2024 · AG
Antibody Production and Testing Core (APTC)$338,571
U19 · FY2024 · AG · contact PI
Proof-of-Concept and Mechanistic Studies to Repurpose Erectile Dysfunction Drugs for Elderly Females$692,527
R01 · FY2023 · AG
Proof-of-Concept and Mechanistic Studies to Repurpose Erectile Dysfunction Drugs for Elderly Females$422,499
R01 · FY2023 · AG
Proof-of-Concept and Mechanistic Studies to Repurpose Erectile Dysfunction Drugs for Elderly Females$692,527
R01 · FY2022 · AG
Proof-of-Concept and Mechanistic Studies to Repurpose Erectile Dysfunction Drugs for Elderly Females$693,892
R01 · FY2021 · AG